Skip to main content
Clinical Trials/IRCT20171216037889N1
IRCT20171216037889N1
Recruiting
Phase 3

Evaluation of the efficacy of oral administration of Cinnamomum tamala with placebo in patients with depressive disorder

Iran University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Iran University of Medical Sciences
Enrollment
50
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • presence of Major Depressive Disorder based on DSM\-5 criteria
  • baseline Hamilton Depression Rating Scale (HAM\-D) (17\-item) score of at least 18
  • 18\-60 years old

Exclusion Criteria

  • presence of psychosis
  • any other diagnosis in axis I and II;
  • receiving psychotropic medications
  • receiving any antidepressants during past one month or ECT during past two months;
  • hypothyroidism
  • cardiovascular problems
  • pregnancy or nursing women

Outcomes

Primary Outcomes

Not specified

Similar Trials